+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Critical Limb Ischemia Treatment Market - Global Forecast 2026-2032- Product Image
Critical Limb Ischemia Treatment Market - Global Forecast 2026-2032- Product Image
New

Critical Limb Ischemia Treatment Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 185 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5967998
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Critical Limb Ischemia Treatment Market is undergoing a period of transformation, propelled by advances in medical technology and increasing demands for integrated, efficient care pathways. Senior leaders face new complexities as evolving patient demographics and regulatory shifts redefine treatment priorities.

Market Snapshot: Critical Limb Ischemia Treatment Market

In 2025, the Critical Limb Ischemia Treatment Market reached USD 4.87 billion, expanding to USD 5.33 billion in 2026, and is anticipated to attain USD 9.20 billion by 2032, according to recent analysis. The market is witnessing a robust CAGR of 9.50%. Growth is shaped by an aging population, higher prevalence of related comorbidities, and ongoing advancements in peripheral arterial disease management. Decision-makers in healthcare organizations are emphasizing solutions that deliver measurable clinical improvements, enhanced operational efficiency, and alignment with payer and regulatory expectations.

Scope & Segmentation

  • Treatment Modalities: Endovascular procedures including Angioplasty (both Drug Coated and Plain Old Balloon types), Atherectomy (Directional, Laser, Orbital, Rotational), Stenting (Bare Metal and Drug Eluting), as well as Pharmacotherapy interventions such as Antiplatelet Agents, Thrombolytics, and Vasodilators. Surgical options include Bypass (using Autologous Vein or Synthetic Grafts) and Endarterectomy, and Supportive Care encompassing Hyperbaric Oxygen Therapy, Pain Management, and Wound Care.
  • Device Types: Atherectomy devices across modalities, Balloons (Drug Coated, Plain Old), Embolic Protection Devices (Distal Filters, Proximal Occlusion Balloons), Stents (Bare Metal, Covered, Drug Eluting), and Vascular Grafts (Autologous Vein, Synthetic).
  • End Users: Ambulatory Surgery Centers (both hospital-owned and independent), Hospitals in both public and private sectors, and Specialty Vascular Centers serving distinct clinical needs.
  • Distribution Channels: Direct Sales, Hospital Pharmacies covering inpatient and outpatient needs, and Third Party Distributors including both Retail and Wholesale Pharmacies.
  • Geographic Coverage: Americas, Europe, Middle East & Africa, and Asia-Pacific, ensuring comprehensive analysis of global healthcare delivery and regional market dynamics.

Key Takeaways

  • There is heightened clinical urgency for limb salvage and chronic wound management, prompting a shift from isolated interventions to holistic care models that encourage multidisciplinary collaboration and drive innovation.
  • Advances in endovascular devices and adjunctive therapies are influencing capital investment strategies and demanding updated clinician training programs to meet evolving procedural requirements.
  • Stakeholder demands are broadening to encompass not just short-term procedural outcomes but long-term patient healing, requiring providers to demonstrate sustained value to both payers and regulatory agencies.
  • Care delivery models are restructuring, with ambulatory centers, hospitals, and specialized vascular clinics realigning roles, which has implications for procedural allocations, procurement strategies, and post-treatment follow-up care.
  • Platform versatility, support for bundled payment models, and a commitment to evidence-driven value are emerging as key differentiators in the device marketplace, positioning suppliers for durable contracting and purchasing relationships.

Tariff Impact and Supply Chain Adaptations

  • Tariffs introduced in the United States in 2025 have driven changes in supply chain strategies for manufacturers, particularly those sourcing internationally for device components and specialized medical materials.
  • Manufacturers and distributors are implementing dual-sourcing, establishing regionalized production hubs, and leveraging tariff mitigation strategies through product reclassification and enhanced use of local content.
  • Healthcare providers are focused on procuring modular and interoperable devices, pursuing inventory management initiatives to minimize risk and maintain steady access to crucial technologies for patient care.
  • Distributors are expanding nearshoring capabilities and investing in bonded warehouse solutions, supporting cost stability and timely product replenishment to reinforce supply chain resilience.

Methodology & Data Sources

This report features insights from direct interviews with vascular surgeons, interventionalists, procurement leaders, and wound care professionals, complemented by structured advisory roundtables. Secondary research incorporates clinical literature, regulatory filings, guideline updates, and trade policy analysis. Rigorous data triangulation and expert review ensure accuracy and practical relevance in the analysis of the CLI treatment ecosystem.

Why This Report Matters

  • Delivers actionable intelligence for strategic decision-making amidst advancing technology and evolving reimbursement structures in the Critical Limb Ischemia Treatment Market.
  • Enables robust investment evaluation by highlighting how market segmentation, regional characteristics, and emerging care models inform device and therapy adoption as well as ROI scenarios.
  • Supports supply chain and procurement teams in refining purchasing protocols and inventory strategies, aligned to industry best practices and recent tariff-driven changes.

Conclusion

Coordinated action across clinical, commercial, and operational domains is fundamental for advancing limb preservation and maximizing healthcare value. Adapting to new care models and regulatory environments will be critical in maintaining competitive positioning within this evolving market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Critical Limb Ischemia Treatment Market, by Treatment Modality
8.1. Endovascular Procedures
8.1.1. Angioplasty
8.1.1.1. Drug Coated Balloon
8.1.1.2. Plain Old Balloon
8.1.2. Atherectomy
8.1.2.1. Directional Atherectomy
8.1.2.2. Laser Atherectomy
8.1.2.3. Orbital Atherectomy
8.1.2.4. Rotational Atherectomy
8.1.3. Stenting
8.1.3.1. Bare Metal Stent
8.1.3.2. Drug Eluting Stent
8.2. Pharmacotherapy
8.2.1. Antiplatelet Agents
8.2.2. Thrombolytics
8.2.3. Vasodilators
8.3. Supportive Care
8.3.1. Hyperbaric Oxygen Therapy
8.3.2. Pain Management
8.3.3. Wound Care
8.4. Surgical Procedures
8.4.1. Bypass Surgery
8.4.1.1. Autologous Vein Graft
8.4.1.2. Synthetic Graft
8.4.2. Endarterectomy
9. Critical Limb Ischemia Treatment Market, by Device Type
9.1. Atherectomy Devices
9.1.1. Directional Atherectomy
9.1.2. Laser Atherectomy
9.1.3. Orbital Atherectomy
9.1.4. Rotational Atherectomy
9.2. Balloons
9.2.1. Drug Coated Balloon
9.2.2. Plain Old Balloon
9.3. Embolic Protection Devices
9.3.1. Distal Filter
9.3.2. Proximal Occlusion Balloon
9.4. Stents
9.4.1. Bare Metal Stent
9.4.2. Covered Stent
9.4.3. Drug Eluting Stent
9.5. Vascular Grafts
9.5.1. Autologous Vein Graft
9.5.2. Synthetic Graft
10. Critical Limb Ischemia Treatment Market, by Distribution Channel
10.1. Direct Sales
10.2. Hospital Pharmacies
10.2.1. Inpatient
10.2.2. Outpatient
10.3. Third Party Distributors
10.3.1. Retail Pharmacies
10.3.2. Wholesale Distributors
11. Critical Limb Ischemia Treatment Market, by End User
11.1. Ambulatory Surgery Centers
11.1.1. Hospital Owned Centers
11.1.2. Standalone Centers
11.2. Hospitals
11.2.1. Private Hospitals
11.2.2. Public Hospitals
11.3. Specialty Vascular Centers
11.3.1. Hospital Owned Centers
11.3.2. Independent Centers
12. Critical Limb Ischemia Treatment Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Critical Limb Ischemia Treatment Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Critical Limb Ischemia Treatment Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Critical Limb Ischemia Treatment Market
16. China Critical Limb Ischemia Treatment Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Abbott Laboratories
17.6. Ambulero Inc
17.7. Amgen Inc.
17.8. Antidote Therapeutics Inc
17.9. Athersys Inc
17.10. Boston Scientific Corporation
17.11. Caladrius Biosciences Inc
17.12. Cardiovascular Systems, Inc.
17.13. Cesca Therapeutics Inc.
17.14. Constant Therapeutics LLC
17.15. Cynata Therapeutics Ltd
17.16. Eli Lilly and Company
17.17. Gurus BioPharm Inc
17.18. Helixmith Co Ltd
17.19. Hemostemix Inc
17.20. ID Pharma Co Ltd
17.21. ImmuneCyte Inc
17.22. Ixaka Ltd
17.23. LimFlow SA
17.24. Lisata Therapeutics
17.25. Medtronic plc
17.26. Micro Medical Solutions
17.27. Novartis AG
17.28. Pluristem Therapeutics Inc.
17.29. Rexgenero Ltd.
17.30. Sanofi S.A.
17.31. Stempeutics Research Pvt Ltd.
17.32. Teva Pharmaceutical Industries Ltd.
List of Figures
FIGURE 1. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ENDOVASCULAR PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ENDOVASCULAR PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ENDOVASCULAR PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ENDOVASCULAR PROCEDURES, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ANGIOPLASTY, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ANGIOPLASTY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ANGIOPLASTY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ANGIOPLASTY, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DRUG COATED BALLOON, BY REGION, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DRUG COATED BALLOON, BY GROUP, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DRUG COATED BALLOON, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY PLAIN OLD BALLOON, BY REGION, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY PLAIN OLD BALLOON, BY GROUP, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY PLAIN OLD BALLOON, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ATHERECTOMY, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ATHERECTOMY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ATHERECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ATHERECTOMY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY LASER ATHERECTOMY, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY LASER ATHERECTOMY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY LASER ATHERECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ORBITAL ATHERECTOMY, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ORBITAL ATHERECTOMY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ORBITAL ATHERECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ROTATIONAL ATHERECTOMY, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ROTATIONAL ATHERECTOMY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ROTATIONAL ATHERECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY STENTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY STENTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY STENTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY STENTING, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY BARE METAL STENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY BARE METAL STENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY BARE METAL STENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DRUG ELUTING STENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DRUG ELUTING STENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DRUG ELUTING STENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ANTIPLATELET AGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ANTIPLATELET AGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ANTIPLATELET AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY THROMBOLYTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY THROMBOLYTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY THROMBOLYTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY VASODILATORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY VASODILATORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY VASODILATORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY HYPERBARIC OXYGEN THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY HYPERBARIC OXYGEN THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY HYPERBARIC OXYGEN THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY WOUND CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY WOUND CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY WOUND CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY BYPASS SURGERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY BYPASS SURGERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY BYPASS SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY BYPASS SURGERY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY AUTOLOGOUS VEIN GRAFT, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY AUTOLOGOUS VEIN GRAFT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY AUTOLOGOUS VEIN GRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SYNTHETIC GRAFT, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SYNTHETIC GRAFT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SYNTHETIC GRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ENDARTERECTOMY, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ENDARTERECTOMY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ENDARTERECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ATHERECTOMY DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ATHERECTOMY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ATHERECTOMY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ATHERECTOMY DEVICES, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY LASER ATHERECTOMY, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY LASER ATHERECTOMY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY LASER ATHERECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ORBITAL ATHERECTOMY, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ORBITAL ATHERECTOMY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ORBITAL ATHERECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ROTATIONAL ATHERECTOMY, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ROTATIONAL ATHERECTOMY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ROTATIONAL ATHERECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY BALLOONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY BALLOONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY BALLOONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY BALLOONS, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DRUG COATED BALLOON, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DRUG COATED BALLOON, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DRUG COATED BALLOON, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY PLAIN OLD BALLOON, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY PLAIN OLD BALLOON, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY PLAIN OLD BALLOON, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DISTAL FILTER, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DISTAL FILTER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DISTAL FILTER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY PROXIMAL OCCLUSION BALLOON, BY REGION, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY PROXIMAL OCCLUSION BALLOON, BY GROUP, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY PROXIMAL OCCLUSION BALLOON, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY STENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY STENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY BARE METAL STENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY BARE METAL STENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY BARE METAL STENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY COVERED STENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY COVERED STENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY COVERED STENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DRUG ELUTING STENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DRUG ELUTING STENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DRUG ELUTING STENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY AUTOLOGOUS VEIN GRAFT, BY REGION, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY AUTOLOGOUS VEIN GRAFT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY AUTOLOGOUS VEIN GRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SYNTHETIC GRAFT, BY REGION, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SYNTHETIC GRAFT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SYNTHETIC GRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY INPATIENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY INPATIENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY INPATIENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY OUTPATIENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY OUTPATIENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY OUTPATIENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 166. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 167. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY WHOLESALE DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY WHOLESALE DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 169. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY WHOLESALE DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 171. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 172. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 173. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 174. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
TABLE 175. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY HOSPITAL OWNED CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 176. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY HOSPITAL OWNED CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 177. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY HOSPITAL OWNED CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 178. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY STANDALONE CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 179. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY STANDALONE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 180. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY STANDALONE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 181. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 182. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 183. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 184. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 185. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 186. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 187. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 188. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 189. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 190. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 191. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SPECIALTY VASCULAR CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 192. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SPECIALTY VASCULAR CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 193. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SPECIALTY VASCULAR CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 194. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SPECIALTY VASCULAR CENTERS, 2018-2032 (USD MILLION)
TABLE 195. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY HOSPITAL OWNED CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 196. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY HOSPITAL OWNED CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 197. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY HOSPITAL OWNED CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 198. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY INDEPENDENT CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 199. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY INDEPENDENT CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 200. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY INDEPENDENT CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 201. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 202. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 203. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
TABLE 204. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ENDOVASCULAR PROCEDURES, 2018-2032 (USD MILLION)
TABLE 205. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ANGIOPLASTY, 2018-2032 (USD MILLION)
TABLE 206. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ATHERECTOMY, 2018-2032 (USD MILLION)
TABLE 207. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY STENTING, 2018-2032 (USD MILLION)
TABLE 208. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 209. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2032 (USD MILLION)
TABLE 210. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 211. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY BYPASS SURGERY, 2018-2032 (USD MILLION)
TABLE 212. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 213. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ATHERECTOMY DEVICES, 2018-2032 (USD MILLION)
TABLE 214. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY BALLOONS, 2018-2032 (USD MILLION)
TABLE 215. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 216. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
TABLE 217. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 218. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 219. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 220. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
TABLE 221. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 222. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
TABLE 223. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 224. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SPECIALTY VASCULAR CENTERS, 2018-2032 (USD MILLION)
TABLE 225. NORTH AMERICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 226. NORTH AMERICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
TABLE 227. NORTH AMERICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ENDOVASCULAR PROCEDURES, 2018-2032 (USD MILLION)
TABLE 228. NORTH AMERICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ANGIOPLASTY, 2018-2032 (USD MILLION)
TABLE 229. NORTH AMERICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ATHERECTOMY, 2018-2032 (USD MILLION)
TABLE 230. NORTH AMERICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY STENTING, 2018-2032 (USD MILLION)
TABLE 231. NORTH AMERICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 232. NORTH AMERICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2032 (USD MILLION)
TABLE 233. NORTH AMERICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 234. NORTH AMERICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY BYPASS SURGERY, 2018-2032 (USD MILLION)
TABLE 235. NORTH AMERICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 236. NORTH AMERICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ATHERECTOMY DEVICES, 2018-2032 (USD MILLION)
TABLE 237. NORTH AMERICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY BALLOONS, 2018-2032 (USD MILLION)
TABLE 238. NORTH AMERICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 239. NORTH AMERICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
TABLE 240. NORTH AMERICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 241. NORTH AMERICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 242. NORTH AMERICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 243. NORTH AMERICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
TABLE 244. NORTH AMERICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 245. NORTH AMERICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
TABLE 246. NORTH AMERICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 247. NORTH AMERICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SPECIALTY VASCULAR CENTERS, 2018-2032 (USD MILLION)
TABLE 248. LATIN AMERICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 249. LATIN AMERICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
TABLE 250. LATIN AMERICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ENDOVASCULAR PROCEDURES, 2018-2032 (USD MILLION)
TABLE 251. LATIN AMERICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ANGIOPLASTY, 2018-2032 (USD MILLION)
TABLE 252. LATIN AMERICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ATHERECTOMY, 2018-2032 (USD MILLION)
TABLE 253. LATIN AMERICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY STENTING, 2018-2032 (USD MILLION)
TABLE 254. LATIN AMERICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 255. LATIN AMERICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2032 (USD MILLION)
TABLE 256. LATIN AMERICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 257. LATIN AMERICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY BYPASS SURGERY, 2018-2032 (USD MILLION)
TABLE 258. LATIN AMERICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 259. LATIN AMERICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ATHERECTOMY DEVICES, 2018-2032 (USD MILLION)
TABLE 260. LATIN AMERICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY BALLOONS, 2018-2032 (USD MILLION)
TABLE 261. LATIN AMERICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 262. LATIN AMERICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
TABLE 263. LATIN AMERICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 264. LATIN AMERICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 265. LATIN AMERICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 266. LATIN AMERICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
TABLE 267. LATIN AMERICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 268. LATIN AMERICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
TABLE 269. LATIN AMERICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 270. LATIN AMERICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SPECIALTY VASCULAR CENTERS, 2018-2032 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ENDOVASCULAR PROCEDURES, 2018-2032 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ANGIOPLASTY, 2018-2032 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ATHERECTOMY, 2018-2032 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY STENTING, 2018-2032 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE

Companies Mentioned

The key companies profiled in this Critical Limb Ischemia Treatment market report include:
  • Abbott Laboratories
  • Ambulero Inc
  • Amgen Inc.
  • Antidote Therapeutics Inc
  • Athersys Inc
  • Boston Scientific Corporation
  • Caladrius Biosciences Inc
  • Cardiovascular Systems, Inc.
  • Cesca Therapeutics Inc.
  • Constant Therapeutics LLC
  • Cynata Therapeutics Ltd
  • Eli Lilly and Company
  • Gurus BioPharm Inc
  • Helixmith Co Ltd
  • Hemostemix Inc
  • ID Pharma Co Ltd
  • ImmuneCyte Inc
  • Ixaka Ltd
  • LimFlow SA
  • Lisata Therapeutics
  • Medtronic plc
  • Micro Medical Solutions
  • Novartis AG
  • Pluristem Therapeutics Inc.
  • Rexgenero Ltd.
  • Sanofi S.A.
  • Stempeutics Research Pvt Ltd.
  • Teva Pharmaceutical Industries Ltd.

Table Information

Report AttributeDetails
No. of Pages185
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 5.33 Billion
Forecasted Market Value ( USD ) by 2032 $ 9.2 Billion
Compound Annual Growth Rate9.5%
Regions CoveredGlobal
No. of Companies Mentioned29

Related Topics

Related Reports

Critical Limb Ischemia Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025-2033 - Product Image

Critical Limb Ischemia Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025-2033

  • Report
  • 194 Pages
  • Global
From
Critical Limb Ischemia Market Report 2025 - Product Image

Critical Limb Ischemia Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Critical Limb Ischemia Treatment - Global Strategic Business Report - Product Image

Critical Limb Ischemia Treatment - Global Strategic Business Report

  • Report
  • 375 Pages
  • Global
From
Critical Limb Ischemia Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035 - Product Image

Critical Limb Ischemia Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035

  • Report
  • 100 Pages
  • Global
From
Peripheral Arterial Disease Therapeutics Market - Global Forecast 2026-2032 - Product Image

Peripheral Arterial Disease Therapeutics Market - Global Forecast 2026-2032

  • Report
  • 185 Pages
  • Global
From

About the Critical Limb Ischemia Drug Market

Critical Limb Ischemia (CLI) is a severe form of peripheral artery disease (PAD) that affects the lower extremities. It is caused by a narrowing of the arteries that supply blood to the legs, leading to a lack of oxygen and nutrients to the affected area. CLI can lead to severe pain, ulcers, and even amputation. The CLI drug market is a subset of the larger cardiovascular drug market. It is composed of drugs that are used to treat CLI, such as anticoagulants, antiplatelet agents, and vasodilators. These drugs are used to reduce the risk of further narrowing of the arteries, reduce pain, and improve blood flow to the affected area. The CLI drug market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Pfizer, Merck, Sanofi, Bristol-Myers Squibb, and Novartis. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.